– UK, Kings Lynn – BB Healthcare Trust plc (LON: BBH), are pleased to announce the appointment of Professor Tony Young, OBE, as a Non-Executive Director of the Company with immediate effect.
“I am delighted to welcome Professor Young to the Board as a Non-Executive Director. He brings a wealth of experience in medical innovation, which will further strengthen our Board and we look forward to working with him.” said Board Chairman, Randeep Grewal.
Professor Young will also be appointed as a member of the Audit Committee and Management Engagement Committee following his appointment to the board.
About Professor Tony Young
Professor Young is a practising frontline NHS Consultant Urological Surgeon, Director of Medical Innovation at Anglia Ruskin University, President of the Institute of Decontamination Sciences, and National Clinical Director for Innovation for the NHS. He has founded four Med-Tech start-ups and also co-founded the £500m Anglia Ruskin Med-Tech Campus.
In 2014, he was appointed as National Clinical Director for Innovation at NHS England, and in February 2016 became the first National Clinical Lead for Innovation. In this role, he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS as well as promoting economic growth through innovation. In 2015, Professor Young founded the NHS Clinical Entrepreneur Programme, which has become the world’s largest entrepreneurial workforce development programme for clinicians.
Professor Young was previously a member of the Royal College of Surgeon’s Commission on the Future of Surgery (2017 – 2018). In the 2019 New Year’s Honours list, Professor Young was awarded the OBE for services to clinical leadership.
For more information: http://www.bbhealthcaretrust.com/en
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
